Afsheen Raza

Hamad Medical Corporation

Dr. Afsheen Raza is a research scientist with extensive experience in cutting-edge molecular biology/immunology research and cancer clinical trials currently working at the Translational Cancer Research Institute of National Center of Cancer Care and Research (NCCCR) and Hamad Medical Corporation, Qatar. She is trained in Cancer Biology and Therapeutics at Harvard Medical School, USA, and in Molecular Biology at Aga Khan University. She has extensive experience in conducting large study grants and clinical trials. Her primary research focuses on studying tumor-host immune interactions to immunotherapeutic strategies and is also engaged in establishing immune-monitoring platforms/analytical tools to evaluate novel immune-modulators and cancer antigen-specific immune cells that will serve as a foundation for translational research. Apart from 10 years of research experience and 39+ peer-reviewed publications in high-impact journals, Dr. Raza has authored a book chapter and is a reviewer for several journals. She is Internationally recognized for her scientific contribution to cancer immunology and immunotherapy – Academic Editor for PLOS ONE journal, Guest Editor for prestigious journal of Frontiers in Immunology and Special Collection in Biomarker Insight for SAGE Publishing. She has six years of experience in mentoring and supervising Masters and Ph.D. students in their research projects and in teaching immunology and molecular biology curriculum and lab techniques to rotating clinical fellows from Hematology, Immunology, and Allergy programs. h-index=14 , ORCID ID: https://orcid.org/ 0000-0002-0264-3304

1chapters authored